TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8499815

Group type: EXPERIMENTAL
Intervention: Individualised reminder chart with explanation from a pharmacist
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Individualised reminder chart without explanation
Number of subjects: 197

Group type: COMPARATOR
Intervention: No reminder chart with nurse counseling
Number of subjects: 197

Group type: COMPARATOR
Intervention: No reminder chart with pharmacist counseling
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Individualised reminder chart
Number of subjects: 197

Group type: COMPARATOR
Intervention: No reminder chart
Number of subjects: 197
Study: 3554457

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pentamidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both TMP-SMZ and Pentamidine
Number of subjects: 0
Study: 30159992

Group type: EXPERIMENTAL
Intervention: Public education program (Keep Watch @ Public Pools)
Number of subjects: 6930

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 6930
Study: 27876086

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair of the rotator cuff with release of the superior transverse scapular ligament
Number of subjects: 42

Group type: COMPARATOR
Intervention: Arthroscopic repair of the rotator cuff without release of the superior transverse scapular ligament
Number of subjects: 42
Study: 24224648

Group type: EXPERIMENTAL
Intervention: Prostate HistoScanning™ (PHS)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard TRUS-guided biopsies
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard TTB
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard pathological analysis of whole-mount prostatectomy specimens
Number of subjects: 105
Study: 22101222

Group type: EXPERIMENTAL
Intervention: Researcher led presentation of information during trial introduction meetings
Number of subjects: 149
Study: 21246854

Group type: EXPERIMENTAL
Intervention: Auricular point sticking (group A) - semen vaccariae fixed with plaster on various ear points, pressed 3 times daily for 5 mm each time, alternating sides every two days.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Combined therapy of auricular point sticking and body acupuncture (group B) - same ear points as group A, plus body acupuncture at specific points (Zhongwan, Juanyuan, Tiansho, Zusanli, Sanyinjiao), applied once every two days.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Comparison of thin persons with spleen and stomach deficiency constitution vs. normal constitution.
Number of subjects: 100
Study: 18381948

Group type: EXPERIMENTAL
Intervention: i.v. cyclophosphamide/methotrexate/5‐fluorouracil (CMF) polychemotherapy
Number of subjects: 424
Study: 15765393

Group type: EXPERIMENTAL
Intervention: IBS-D
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: IBS-M
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: IBS-C
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: IBS-A
Number of subjects: 317
Study: 14527649

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Home polysomnography
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Subjective sleep assessments
Number of subjects: 40
Study: 10214748

Group type: EXPERIMENTAL
Intervention: Rapid titration of pramipexole (full converted dose the day after stopping the former agonist)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Slow titration of pramipexole (up to 8 weeks to reach equivalent dosage)
Number of subjects: 16
Study: 8607388

Group type: EXPERIMENTAL
Intervention: Maintenance of sinus rhythm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 0
Study: 1888251

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 31042578

Group type: EXPERIMENTAL
Intervention: Preloaded fiducial needles (PLNs)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Back-loaded fiducial needles (BLNs)
Number of subjects: 44
Study: 27560455

Group type: EXPERIMENTAL
Intervention: Processing Speed Training (PST)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 62
Study: 25890597

Group type: EXPERIMENTAL
Intervention: Support group intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Routine follow-up (Control)
Number of subjects: 73
Study: 24451865

Group type: EXPERIMENTAL
Intervention: Anorganic bovine bone mineral (BOV, n=12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Calcium phosphosilicate putty (PUT, n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No graft (CTRL, n=6)
Number of subjects: 24
Study: 21835837

Group type: EXPERIMENTAL
Intervention: EMONO (50% oxygen and 50% N(2)O)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (50% oxygen and 50% nitrogen)
Number of subjects: 36
Study: 19352247

Group type: EXPERIMENTAL
Intervention: Particulate injections (5 bone marrow aspirates and cyst injections)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Steroid injections (2 injections)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Bone marrow injection
Number of subjects: 5
Study: 17584671

Group type: EXPERIMENTAL
Intervention: Body surface potential mapping (BSPM)
Number of subjects: 110
Study: 15162891

Group type: EXPERIMENTAL
Intervention: SFGC 62.5 mg administered over 30 minutes
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SFGC 125 mg administered over 60 minutes
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SFGC 62.5 mg administered over 4 minutes (second dose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SFGC 125 mg administered over 7 minutes (second dose)
Number of subjects: 14
Study: 12296486

Group type: EXPERIMENTAL
Intervention: Music distraction (attention diverting)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Attention focusing (attending to procedural sensations)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ignoring (coping behavior during prior procedure)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 9844330

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg at bedtime as maintenance therapy for one year
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 7915853

Group type: EXPERIMENTAL
Intervention: GLP-1 (41 pmol/kg/h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Peptide YY (50 pmol/kg/h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study: 2491145

Group type: EXPERIMENTAL
Intervention: Educative/didactic intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic/support intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 405433

Group type: EXPERIMENTAL
Intervention: APPG (4.8 X 10(6) units of aqueous procaine penicillin G intramuscularly plus 1 g of probenecid orally)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: TMP‐SMZ‐9 (nine tablets of trimethoprim‐sulfamethoxazole; 720 mg of TMP and 3,600 mg of SMZ, orally as a single dose)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: TMP‐SMZ‐12 (12 tablets of TMP‐SMZ; 960 mg of TMP and 4,800 mg of SMZ, orally as two doses of six tablets taken at a 6‐hr interval)
Number of subjects: 271

Group type: COMPARATOR
Intervention: APPG
Number of subjects: 271

Group type: COMPARATOR
Intervention: Neisseria gonorrhoeae treatment failures
Number of subjects: 271
Study: 30346318

Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lithotomy position
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both positions
Number of subjects: 21
Study: 31185033

Group type: EXPERIMENTAL
Intervention: Pre-frail individuals
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Robust and pre-frail subjects
Number of subjects: 1280
Study: 27402427

Group type: EXPERIMENTAL
Intervention: Short (6-mm) dental implants (TG)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sinus floor elevation (SFE) with longer (≥10-mm) implants (CG)
Number of subjects: 53
Study: 25865751

Group type: EXPERIMENTAL
Intervention: 10 mg/ml of pectin
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 0, 3 and 10 mg/ml of pectin
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-methoxy pectin
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-methoxy pectin
Number of subjects: 19
Study: 23761003

Group type: EXPERIMENTAL
Intervention: Rolling walker with a laser beam visual cue
Number of subjects: 22

Group type: COMPARATOR
Intervention: Without laser beam visual cue
Number of subjects: 22
Study: 20030777

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching-control
Number of subjects: 0
Study: 19621660

Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g intravenously after induction of anesthesia
Number of subjects: 208

Group type: COMPARATOR
Intervention: No prophylactic antibiotics
Number of subjects: 208
Study: 16724543

Group type: EXPERIMENTAL
Intervention: Bronchobos capsules (750 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Mucopront capsules (750 mg)
Number of subjects: 18
Study: 15255911

Group type: EXPERIMENTAL
Intervention: Psychological and educational counselling (12-week intervention programme)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 11525101

Group type: EXPERIMENTAL
Intervention: Dietary restriction during FOBT
Number of subjects: 5

Group type: COMPARATOR
Intervention: No dietary restriction during FOBT
Number of subjects: 5
Study: 9257324

Group type: EXPERIMENTAL
Intervention: Oral ketamine (60 mg administered six times/d)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 7687093

Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Midodrine (any dose)
Number of subjects: 97
Study: 3829296

Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg with 150 ml water
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg with no further fluid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with 150 ml water
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with no further fluid
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral ranitidine 150 mg (both groups)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (both groups)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with a sip of water
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ranitidine (both groups)
Number of subjects: 100
Study: 31126694

Group type: EXPERIMENTAL
Intervention: Contezolid 1200 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Contezolid 1600 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Contezolid 800 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 28079776

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery protocol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine postoperative care (Control)
Number of subjects: 100
Study: 26418678

Group type: EXPERIMENTAL
Intervention: Instructional video on sputum submission
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 200
Study: 22643213

Group type: EXPERIMENTAL
Intervention: M72/AS01
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: M72/AS02
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Mtb72F/AS02
Number of subjects: 110

Group type: COMPARATOR
Intervention: M72/saline
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: AS01
Number of subjects: 110
Study: 21779740

Group type: COMPARATOR
Intervention: Electroacupuncture pulse stimulation therapy alone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Massage combined with electroacupuncture pulse stimulation therapy
Number of subjects: 96
Study: 19220275

Group type: EXPERIMENTAL
Intervention: Pramipexole (0.5 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-dopa (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg)
Number of subjects: 12
Study: 16424872

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study: 14686887

Group type: EXPERIMENTAL
Intervention: Autonomy support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rewards
Number of subjects: 0
Study: 11535972

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Sildenafil alone
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Sildenafil and L-Arginine
Number of subjects: 116
Study: 9597557

Group type: EXPERIMENTAL
Intervention: Eprosartan 100 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Eprosartan 200 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Eprosartan 400 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Eprosartan 800 mg
Number of subjects: 23
Study: 7841434

Group type: EXPERIMENTAL
Intervention: Model 2000 disposable‐head Heaf gun
Number of subjects: 1410

Group type: COMPARATOR
Intervention: fixed‐head Heaf gun
Number of subjects: 1410
Study: 2893037

Group type: EXPERIMENTAL
Intervention: Thrombolysis with recombinant tissue-type plasminogen activator (rTPA) and immediate percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Non-invasive strategy with thrombolysis (rTPA), heparin, and acetylsalicylic acid without immediate angiography and PTCA
Number of subjects: 367
Study: 31169023

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab treatment for choroidal neovascularization due to pathologic myopia
Number of subjects: 200

Group type: COMPARATOR
Intervention: Income level
Number of subjects: 200
Study: 28472901

Group type: EXPERIMENTAL
Intervention: Stress management training and standard care
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 202
Study: 26546548

Group type: EXPERIMENTAL
Intervention: ChAd3-EBO-Z (1 × 10(10) pu, 2·5 × 10(10) pu, 5 × 10(10) pu, 1 × 10(11) pu)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: ChAd3-EBO-Z (1 × 10(11) pu)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo (2 × 10(8) pfu)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 111
Study: 24077657

Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (family‐focused therapy, interpersonal and social rhythm therapy, or cognitive‐behavioral therapy)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Collaborative care (three‐session comparison treatment)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy
Number of subjects: 269

Group type: COMPARATOR
Intervention: Collaborative care
Number of subjects: 269
Study: 24032193

Group type: EXPERIMENTAL
Intervention: Behavior training with head needling retention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Behavior training after acupuncture treatment
Number of subjects: 60
Study: 20452733

Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via iontophoresis or phonophoresis
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via iontophoresis
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Transdermal steroid delivery via phonophoresis
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo delivery via iontophoresis or phonophoresis
Number of subjects: 62
Study: 18984532

Group type: EXPERIMENTAL
Intervention: Robotic navigation system (RNS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional catheter ablation
Number of subjects: 50
Study: 16888420

Group type: EXPERIMENTAL
Intervention: PK‐TURP with 0.9% NaCl irrigation fluid
Number of subjects: 42

Group type: COMPARATOR
Intervention: TURP with 1.5% glycine irrigation fluid
Number of subjects: 42
Study: 12409681

Group type: EXPERIMENTAL
Intervention: Montgomery-Asberg Depression Rating Scale (MADRS)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating Scale (HAM-D)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Clinical Global Impressions Severity (CGI-S)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Clinical Global Impressions Improvement (CGI-I)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 9891827

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Surgical bypass with implantation of the internal mammary artery
Number of subjects: 134
Study: 7972572

Group type: EXPERIMENTAL
Intervention: Inhalation of 35% CO2/65% O2 gas mixture
Number of subjects: 71

Group type: COMPARATOR
Intervention: Inhalation of air (placebo condition)
Number of subjects: 71
Study: 2741903

Group type: EXPERIMENTAL
Intervention: Telephone call prenotification plus lottery incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postcard plus lottery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-page survey with lottery announcement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monetary incentive of $5.00 contingent on response
Number of subjects: 0
Study: 4907811

Group type: EXPERIMENTAL
Intervention: Propranolol (120-320 mg daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31718825

Group type: EXPERIMENTAL
Intervention: Magmaris
Number of subjects: 482

Group type: COMPARATOR
Intervention: Orsiro
Number of subjects: 482
Study: 31105142

Group type: EXPERIMENTAL
Intervention: Mono‐energetic 40‐60 keV images from spectral CCTA using SDCT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional 120 kVp images
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional 100 kVp images
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Spectral images
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 40‐50 keV images
Number of subjects: 60
Study: 29797990

Group type: EXPERIMENTAL
Intervention: Anti-anxiety and anti-depression treatment (experimental group)
Number of subjects: 248

Group type: COMPARATOR
Intervention: No anti-anxiety and anti-depression treatment (control group)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Anti-anxiety and anti-depression treatment (experimental group) for tinnitus
Number of subjects: 248

Group type: COMPARATOR
Intervention: No anti-anxiety and anti-depression treatment (control group) for tinnitus
Number of subjects: 248
Study: 23965700

Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter
Number of subjects: 200

Group type: COMPARATOR
Intervention: No indwelling urinary catheter
Number of subjects: 200
Study: 21366927

Group type: EXPERIMENTAL
Intervention: Home‐Heart‐Walk intervention
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 166
Study: 19657075

Group type: EXPERIMENTAL
Intervention: Visual cues indicating grasp of a virtual object during reaching in the force field
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual cues indicating object release in the absence of forces
Number of subjects: 0
Study: 17303710

Group type: EXPERIMENTAL
Intervention: 100% oxygen breathing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vitamin C (3-g intravenous infusion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Room air breathing
Number of subjects: 12
Study: 15108068

Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Renal transplant recipients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy adults
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 14
Study: 11936388

Group type: EXPERIMENTAL
Intervention: Local warming (Warm Up, Augustine Medical)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Systemic warming (Bair Hugger, Augustine Medical)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Warmed patients (both local and systemic)
Number of subjects: 421
Study: 9892907

Group type: EXPERIMENTAL
Intervention: Interferon-gamma treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 7996318

Group type: EXPERIMENTAL
Intervention: Gamma Nail (GN)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Compression Hip Screw (CHS)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study: 2697199

Group type: EXPERIMENTAL
Intervention: mazindol (2 mg/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 4584640

Group type: EXPERIMENTAL
Intervention: Deglycyrrhizinated liquorice extract (760 mg three times daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 31665172

Group type: EXPERIMENTAL
Intervention: MR13A10A
Number of subjects: 149

Group type: COMPARATOR
Intervention: Original rocuronium
Number of subjects: 149
Study: 28405623

Group type: EXPERIMENTAL
Intervention: Routine BCG vaccination at birth
Number of subjects: 149

Group type: COMPARATOR
Intervention: Delayed BCG vaccination at 8 weeks
Number of subjects: 149
Study: 26443438

Group type: EXPERIMENTAL
Intervention: R25 Reciproc preparation
Number of subjects: 341

Group type: COMPARATOR
Intervention: Conventional hand filing preparation
Number of subjects: 341
Study: 24122103

Group type: EXPERIMENTAL
Intervention: Weight loss group
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Weight gain group
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Unaltered weight group
Number of subjects: 141
Study: 21602574

Group type: EXPERIMENTAL
Intervention: CRT plus an ICD
Number of subjects: 1077

Group type: COMPARATOR
Intervention: ICD alone
Number of subjects: 1077
Study: 19491985

Group type: EXPERIMENTAL
Intervention: Trypan blue used during cataract surgery
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no trypan blue used)
Number of subjects: 15
Study: 16293363

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization
Number of subjects: 63

Group type: COMPARATOR
Intervention: Myomectomy
Number of subjects: 63
Study: 16825962

Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 315

Group type: COMPARATOR
Intervention: Unreamed intramedullary nailing
Number of subjects: 315